nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—Diphenhydramine—atopic dermatitis	0.405	1	CrCtD
Dextropropoxyphene—CYP3A7—Tacrolimus—atopic dermatitis	0.0248	0.114	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0248	0.114	CbGbCtD
Dextropropoxyphene—CYP2C8—Mometasone—atopic dermatitis	0.0228	0.104	CbGbCtD
Dextropropoxyphene—Modafinil—Dimenhydrinate—atopic dermatitis	0.0195	0.0634	CrCrCtD
Dextropropoxyphene—Bepridil—Diphenhydramine—atopic dermatitis	0.0182	0.0592	CrCrCtD
Dextropropoxyphene—Toremifene—Diphenhydramine—atopic dermatitis	0.0182	0.0592	CrCrCtD
Dextropropoxyphene—Phenylbutazone—Diphenhydramine—atopic dermatitis	0.0151	0.049	CrCrCtD
Dextropropoxyphene—Orphenadrine—Dimenhydrinate—atopic dermatitis	0.0147	0.0476	CrCrCtD
Dextropropoxyphene—Alverine—Diphenhydramine—atopic dermatitis	0.0145	0.0471	CrCrCtD
Dextropropoxyphene—Isopropamide—Diphenhydramine—atopic dermatitis	0.0145	0.0471	CrCrCtD
Dextropropoxyphene—CYP2C8—Loratadine—atopic dermatitis	0.0131	0.06	CbGbCtD
Dextropropoxyphene—Diphenhydramine—Dimenhydrinate—atopic dermatitis	0.013	0.0423	CrCrCtD
Dextropropoxyphene—Eprazinone—Diphenhydramine—atopic dermatitis	0.0125	0.0407	CrCrCtD
Dextropropoxyphene—Tamoxifen—Diphenhydramine—atopic dermatitis	0.0125	0.0407	CrCrCtD
Dextropropoxyphene—Antazoline—Diphenhydramine—atopic dermatitis	0.0125	0.0407	CrCrCtD
Dextropropoxyphene—CYP3A4—Pimecrolimus—atopic dermatitis	0.0122	0.0559	CbGbCtD
Dextropropoxyphene—Levomethadyl Acetate—Diphenhydramine—atopic dermatitis	0.0121	0.0394	CrCrCtD
Dextropropoxyphene—Methadyl Acetate—Diphenhydramine—atopic dermatitis	0.0121	0.0394	CrCrCtD
Dextropropoxyphene—Doxylamine—Diphenhydramine—atopic dermatitis	0.0105	0.034	CrCrCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0101	0.0462	CbGbCtD
Dextropropoxyphene—CYP3A7—Hydrocortisone—atopic dermatitis	0.0101	0.0462	CbGbCtD
Dextropropoxyphene—Phenoxybenzamine—Diphenhydramine—atopic dermatitis	0.00995	0.0323	CrCrCtD
Dextropropoxyphene—Tripelennamine—Diphenhydramine—atopic dermatitis	0.00948	0.0308	CrCrCtD
Dextropropoxyphene—Trimipramine—Diphenhydramine—atopic dermatitis	0.00926	0.0301	CrCrCtD
Dextropropoxyphene—Modafinil—Diphenhydramine—atopic dermatitis	0.00926	0.0301	CrCrCtD
Dextropropoxyphene—CYP2C9—Loratadine—atopic dermatitis	0.00915	0.0418	CbGbCtD
Dextropropoxyphene—CYP2C9—Diphenhydramine—atopic dermatitis	0.00915	0.0418	CbGbCtD
Dextropropoxyphene—Fentanyl—Diphenhydramine—atopic dermatitis	0.00886	0.0288	CrCrCtD
Dextropropoxyphene—Dimetacrine—Diphenhydramine—atopic dermatitis	0.00886	0.0288	CrCrCtD
Dextropropoxyphene—Pheniramine—Diphenhydramine—atopic dermatitis	0.00867	0.0282	CrCrCtD
Dextropropoxyphene—CYP2D6—Diphenhydramine—atopic dermatitis	0.00836	0.0382	CbGbCtD
Dextropropoxyphene—CYP2D6—Loratadine—atopic dermatitis	0.00836	0.0382	CbGbCtD
Dextropropoxyphene—Methadone—Diphenhydramine—atopic dermatitis	0.00832	0.027	CrCrCtD
Dextropropoxyphene—Alimemazine—Diphenhydramine—atopic dermatitis	0.00771	0.025	CrCrCtD
Dextropropoxyphene—CYP2C8—Hydrocortisone—atopic dermatitis	0.0073	0.0334	CbGbCtD
Dextropropoxyphene—CYP3A4—Tacrolimus—atopic dermatitis	0.00727	0.0332	CbGbCtD
Dextropropoxyphene—Clofedanol—Diphenhydramine—atopic dermatitis	0.00719	0.0234	CrCrCtD
Dextropropoxyphene—Orphenadrine—Diphenhydramine—atopic dermatitis	0.00696	0.0226	CrCrCtD
Dextropropoxyphene—Benzphetamine—Diphenhydramine—atopic dermatitis	0.00696	0.0226	CrCrCtD
Dextropropoxyphene—Benzyl Benzoate—Diphenhydramine—atopic dermatitis	0.00645	0.0209	CrCrCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00629	0.0288	CbGbCtD
Dextropropoxyphene—CYP3A7—Dexamethasone—atopic dermatitis	0.00629	0.0288	CbGbCtD
Dextropropoxyphene—CYP3A4—Loratadine—atopic dermatitis	0.00532	0.0243	CbGbCtD
Dextropropoxyphene—CYP3A4—Methylprednisolone—atopic dermatitis	0.00486	0.0222	CbGbCtD
Dextropropoxyphene—CYP2C8—Dexamethasone—atopic dermatitis	0.00454	0.0207	CbGbCtD
Dextropropoxyphene—CYP3A4—Triamcinolone—atopic dermatitis	0.00369	0.0169	CbGbCtD
Dextropropoxyphene—CYP2C9—Dexamethasone—atopic dermatitis	0.00316	0.0145	CbGbCtD
Dextropropoxyphene—CYP3A4—Betamethasone—atopic dermatitis	0.00316	0.0145	CbGbCtD
Dextropropoxyphene—CYP3A4—Prednisolone—atopic dermatitis	0.00312	0.0143	CbGbCtD
Dextropropoxyphene—CYP3A4—Hydrocortisone—atopic dermatitis	0.00296	0.0135	CbGbCtD
Dextropropoxyphene—CYP3A4—Prednisone—atopic dermatitis	0.00295	0.0135	CbGbCtD
Dextropropoxyphene—CYP2D6—Dexamethasone—atopic dermatitis	0.00289	0.0132	CbGbCtD
Dextropropoxyphene—CYP3A4—Dexamethasone—atopic dermatitis	0.00184	0.00841	CbGbCtD
Dextropropoxyphene—Cardiac arrest—Betamethasone—atopic dermatitis	0.000111	0.00192	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Dexamethasone—atopic dermatitis	0.000111	0.00192	CcSEcCtD
Dextropropoxyphene—Discomfort—Tacrolimus—atopic dermatitis	0.000111	0.00192	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000111	0.00191	CcSEcCtD
Dextropropoxyphene—Confusional state—Tacrolimus—atopic dermatitis	0.000109	0.00188	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Loratadine—atopic dermatitis	0.000108	0.00187	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Mometasone—atopic dermatitis	0.000107	0.00185	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.000107	0.00184	CcSEcCtD
Dextropropoxyphene—Shock—Tacrolimus—atopic dermatitis	0.000106	0.00183	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Prednisolone—atopic dermatitis	0.000106	0.00183	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000106	0.00183	CcSEcCtD
Dextropropoxyphene—Tachycardia—Tacrolimus—atopic dermatitis	0.000105	0.00182	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000105	0.00181	CcSEcCtD
Dextropropoxyphene—Dizziness—Loratadine—atopic dermatitis	0.000105	0.0018	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.000104	0.0018	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.000104	0.00179	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Prednisone—atopic dermatitis	0.000102	0.00176	CcSEcCtD
Dextropropoxyphene—Hypotension—Tacrolimus—atopic dermatitis	0.000101	0.00174	CcSEcCtD
Dextropropoxyphene—Vomiting—Loratadine—atopic dermatitis	0.000101	0.00174	CcSEcCtD
Dextropropoxyphene—Rash—Loratadine—atopic dermatitis	9.97e-05	0.00172	CcSEcCtD
Dextropropoxyphene—Psychotic disorder—Prednisone—atopic dermatitis	9.97e-05	0.00172	CcSEcCtD
Dextropropoxyphene—Dermatitis—Loratadine—atopic dermatitis	9.97e-05	0.00172	CcSEcCtD
Dextropropoxyphene—Headache—Loratadine—atopic dermatitis	9.91e-05	0.00171	CcSEcCtD
Dextropropoxyphene—Bradycardia—Prednisolone—atopic dermatitis	9.89e-05	0.00171	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Triamcinolone—atopic dermatitis	9.81e-05	0.00169	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	9.79e-05	0.00169	CcSEcCtD
Dextropropoxyphene—Insomnia—Tacrolimus—atopic dermatitis	9.77e-05	0.00169	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Triamcinolone—atopic dermatitis	9.75e-05	0.00168	CcSEcCtD
Dextropropoxyphene—Asthenia—Mometasone—atopic dermatitis	9.74e-05	0.00168	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Methylprednisolone—atopic dermatitis	9.73e-05	0.00168	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	9.73e-05	0.00168	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Prednisone—atopic dermatitis	9.7e-05	0.00167	CcSEcCtD
Dextropropoxyphene—Bradycardia—Hydrocortisone—atopic dermatitis	9.66e-05	0.00167	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Tacrolimus—atopic dermatitis	9.63e-05	0.00166	CcSEcCtD
Dextropropoxyphene—Somnolence—Tacrolimus—atopic dermatitis	9.61e-05	0.00166	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Tacrolimus—atopic dermatitis	9.51e-05	0.00164	CcSEcCtD
Dextropropoxyphene—Hallucination—Hydrocortisone—atopic dermatitis	9.44e-05	0.00163	CcSEcCtD
Dextropropoxyphene—Dizziness—Fluocinolone Acetonide—atopic dermatitis	9.4e-05	0.00162	CcSEcCtD
Dextropropoxyphene—Nausea—Loratadine—atopic dermatitis	9.4e-05	0.00162	CcSEcCtD
Dextropropoxyphene—Visual impairment—Prednisolone—atopic dermatitis	9.36e-05	0.00161	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	9.33e-05	0.00161	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Mometasone—atopic dermatitis	9.29e-05	0.0016	CcSEcCtD
Dextropropoxyphene—Constipation—Tacrolimus—atopic dermatitis	9.24e-05	0.00159	CcSEcCtD
Dextropropoxyphene—Bradycardia—Triamcinolone—atopic dermatitis	9.09e-05	0.00157	CcSEcCtD
Dextropropoxyphene—Bradycardia—Methylprednisolone—atopic dermatitis	9.07e-05	0.00157	CcSEcCtD
Dextropropoxyphene—Vomiting—Fluocinolone Acetonide—atopic dermatitis	9.04e-05	0.00156	CcSEcCtD
Dextropropoxyphene—Rash—Fluocinolone Acetonide—atopic dermatitis	8.96e-05	0.00155	CcSEcCtD
Dextropropoxyphene—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	8.96e-05	0.00154	CcSEcCtD
Dextropropoxyphene—Headache—Fluocinolone Acetonide—atopic dermatitis	8.91e-05	0.00154	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Tacrolimus—atopic dermatitis	8.9e-05	0.00154	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Betamethasone—atopic dermatitis	8.9e-05	0.00154	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Dexamethasone—atopic dermatitis	8.9e-05	0.00154	CcSEcCtD
Dextropropoxyphene—Hallucination—Methylprednisolone—atopic dermatitis	8.87e-05	0.00153	CcSEcCtD
Dextropropoxyphene—Eye disorder—Hydrocortisone—atopic dermatitis	8.87e-05	0.00153	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Dexamethasone—atopic dermatitis	8.85e-05	0.00153	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Betamethasone—atopic dermatitis	8.85e-05	0.00153	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Tacrolimus—atopic dermatitis	8.84e-05	0.00152	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Prednisolone—atopic dermatitis	8.68e-05	0.0015	CcSEcCtD
Dextropropoxyphene—Vomiting—Mometasone—atopic dermatitis	8.63e-05	0.00149	CcSEcCtD
Dextropropoxyphene—Visual impairment—Methylprednisolone—atopic dermatitis	8.59e-05	0.00148	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Hydrocortisone—atopic dermatitis	8.57e-05	0.00148	CcSEcCtD
Dextropropoxyphene—Rash—Mometasone—atopic dermatitis	8.56e-05	0.00148	CcSEcCtD
Dextropropoxyphene—Dermatitis—Mometasone—atopic dermatitis	8.55e-05	0.00148	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Tacrolimus—atopic dermatitis	8.54e-05	0.00147	CcSEcCtD
Dextropropoxyphene—Headache—Mometasone—atopic dermatitis	8.5e-05	0.00147	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Hydrocortisone—atopic dermatitis	8.48e-05	0.00146	CcSEcCtD
Dextropropoxyphene—Nausea—Fluocinolone Acetonide—atopic dermatitis	8.45e-05	0.00146	CcSEcCtD
Dextropropoxyphene—Eye disorder—Methylprednisolone—atopic dermatitis	8.33e-05	0.00144	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Methylprednisolone—atopic dermatitis	8.27e-05	0.00143	CcSEcCtD
Dextropropoxyphene—Malnutrition—Hydrocortisone—atopic dermatitis	8.26e-05	0.00142	CcSEcCtD
Dextropropoxyphene—Bradycardia—Betamethasone—atopic dermatitis	8.25e-05	0.00142	CcSEcCtD
Dextropropoxyphene—Bradycardia—Dexamethasone—atopic dermatitis	8.25e-05	0.00142	CcSEcCtD
Dextropropoxyphene—Hallucination—Betamethasone—atopic dermatitis	8.07e-05	0.00139	CcSEcCtD
Dextropropoxyphene—Hallucination—Dexamethasone—atopic dermatitis	8.07e-05	0.00139	CcSEcCtD
Dextropropoxyphene—Nausea—Mometasone—atopic dermatitis	8.06e-05	0.00139	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Methylprednisolone—atopic dermatitis	8.05e-05	0.00139	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Methylprednisolone—atopic dermatitis	8.03e-05	0.00139	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Triamcinolone—atopic dermatitis	7.98e-05	0.00138	CcSEcCtD
Dextropropoxyphene—Vision blurred—Prednisolone—atopic dermatitis	7.97e-05	0.00137	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Methylprednisolone—atopic dermatitis	7.96e-05	0.00137	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Tacrolimus—atopic dermatitis	7.96e-05	0.00137	CcSEcCtD
Dextropropoxyphene—Visual impairment—Betamethasone—atopic dermatitis	7.81e-05	0.00135	CcSEcCtD
Dextropropoxyphene—Visual impairment—Dexamethasone—atopic dermatitis	7.81e-05	0.00135	CcSEcCtD
Dextropropoxyphene—Malnutrition—Methylprednisolone—atopic dermatitis	7.76e-05	0.00134	CcSEcCtD
Dextropropoxyphene—Asthenia—Tacrolimus—atopic dermatitis	7.75e-05	0.00134	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Prednisone—atopic dermatitis	7.75e-05	0.00134	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Prednisone—atopic dermatitis	7.71e-05	0.00133	CcSEcCtD
Dextropropoxyphene—Syncope—Prednisolone—atopic dermatitis	7.58e-05	0.00131	CcSEcCtD
Dextropropoxyphene—Eye disorder—Dexamethasone—atopic dermatitis	7.58e-05	0.00131	CcSEcCtD
Dextropropoxyphene—Eye disorder—Betamethasone—atopic dermatitis	7.58e-05	0.00131	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Prednisolone—atopic dermatitis	7.43e-05	0.00128	CcSEcCtD
Dextropropoxyphene—Syncope—Hydrocortisone—atopic dermatitis	7.41e-05	0.00128	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Tacrolimus—atopic dermatitis	7.39e-05	0.00128	CcSEcCtD
Dextropropoxyphene—Convulsion—Prednisolone—atopic dermatitis	7.33e-05	0.00126	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Hydrocortisone—atopic dermatitis	7.26e-05	0.00125	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Betamethasone—atopic dermatitis	7.24e-05	0.00125	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Dexamethasone—atopic dermatitis	7.24e-05	0.00125	CcSEcCtD
Dextropropoxyphene—Bradycardia—Prednisone—atopic dermatitis	7.19e-05	0.00124	CcSEcCtD
Dextropropoxyphene—Convulsion—Hydrocortisone—atopic dermatitis	7.16e-05	0.00123	CcSEcCtD
Dextropropoxyphene—Dizziness—Tacrolimus—atopic dermatitis	7.15e-05	0.00123	CcSEcCtD
Dextropropoxyphene—Discomfort—Prednisolone—atopic dermatitis	7.11e-05	0.00123	CcSEcCtD
Dextropropoxyphene—Hallucination—Prednisone—atopic dermatitis	7.02e-05	0.00121	CcSEcCtD
Dextropropoxyphene—Syncope—Triamcinolone—atopic dermatitis	6.97e-05	0.0012	CcSEcCtD
Dextropropoxyphene—Syncope—Methylprednisolone—atopic dermatitis	6.96e-05	0.0012	CcSEcCtD
Dextropropoxyphene—Discomfort—Hydrocortisone—atopic dermatitis	6.95e-05	0.0012	CcSEcCtD
Dextropropoxyphene—Vomiting—Tacrolimus—atopic dermatitis	6.87e-05	0.00119	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Triamcinolone—atopic dermatitis	6.84e-05	0.00118	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Methylprednisolone—atopic dermatitis	6.82e-05	0.00118	CcSEcCtD
Dextropropoxyphene—Rash—Tacrolimus—atopic dermatitis	6.81e-05	0.00118	CcSEcCtD
Dextropropoxyphene—Dermatitis—Tacrolimus—atopic dermatitis	6.81e-05	0.00117	CcSEcCtD
Dextropropoxyphene—Shock—Prednisolone—atopic dermatitis	6.79e-05	0.00117	CcSEcCtD
Dextropropoxyphene—Headache—Tacrolimus—atopic dermatitis	6.77e-05	0.00117	CcSEcCtD
Dextropropoxyphene—Convulsion—Triamcinolone—atopic dermatitis	6.74e-05	0.00116	CcSEcCtD
Dextropropoxyphene—Tachycardia—Prednisolone—atopic dermatitis	6.74e-05	0.00116	CcSEcCtD
Dextropropoxyphene—Convulsion—Methylprednisolone—atopic dermatitis	6.72e-05	0.00116	CcSEcCtD
Dextropropoxyphene—Shock—Hydrocortisone—atopic dermatitis	6.63e-05	0.00114	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Hydrocortisone—atopic dermatitis	6.61e-05	0.00114	CcSEcCtD
Dextropropoxyphene—Eye disorder—Prednisone—atopic dermatitis	6.6e-05	0.00114	CcSEcCtD
Dextropropoxyphene—Tachycardia—Hydrocortisone—atopic dermatitis	6.58e-05	0.00113	CcSEcCtD
Dextropropoxyphene—Discomfort—Triamcinolone—atopic dermatitis	6.54e-05	0.00113	CcSEcCtD
Dextropropoxyphene—Discomfort—Methylprednisolone—atopic dermatitis	6.53e-05	0.00113	CcSEcCtD
Dextropropoxyphene—Nausea—Tacrolimus—atopic dermatitis	6.42e-05	0.00111	CcSEcCtD
Dextropropoxyphene—Confusional state—Methylprednisolone—atopic dermatitis	6.39e-05	0.0011	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Prednisone—atopic dermatitis	6.38e-05	0.0011	CcSEcCtD
Dextropropoxyphene—Syncope—Dexamethasone—atopic dermatitis	6.33e-05	0.00109	CcSEcCtD
Dextropropoxyphene—Syncope—Betamethasone—atopic dermatitis	6.33e-05	0.00109	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Prednisone—atopic dermatitis	6.31e-05	0.00109	CcSEcCtD
Dextropropoxyphene—Hypotension—Hydrocortisone—atopic dermatitis	6.3e-05	0.00109	CcSEcCtD
Dextropropoxyphene—Shock—Triamcinolone—atopic dermatitis	6.24e-05	0.00108	CcSEcCtD
Dextropropoxyphene—Insomnia—Prednisolone—atopic dermatitis	6.24e-05	0.00108	CcSEcCtD
Dextropropoxyphene—Shock—Methylprednisolone—atopic dermatitis	6.23e-05	0.00107	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Methylprednisolone—atopic dermatitis	6.21e-05	0.00107	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Betamethasone—atopic dermatitis	6.2e-05	0.00107	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Dexamethasone—atopic dermatitis	6.2e-05	0.00107	CcSEcCtD
Dextropropoxyphene—Tachycardia—Triamcinolone—atopic dermatitis	6.19e-05	0.00107	CcSEcCtD
Dextropropoxyphene—Tachycardia—Methylprednisolone—atopic dermatitis	6.18e-05	0.00107	CcSEcCtD
Dextropropoxyphene—Malnutrition—Prednisone—atopic dermatitis	6.15e-05	0.00106	CcSEcCtD
Dextropropoxyphene—Convulsion—Dexamethasone—atopic dermatitis	6.11e-05	0.00105	CcSEcCtD
Dextropropoxyphene—Convulsion—Betamethasone—atopic dermatitis	6.11e-05	0.00105	CcSEcCtD
Dextropropoxyphene—Insomnia—Hydrocortisone—atopic dermatitis	6.1e-05	0.00105	CcSEcCtD
Dextropropoxyphene—Discomfort—Dexamethasone—atopic dermatitis	5.94e-05	0.00102	CcSEcCtD
Dextropropoxyphene—Discomfort—Betamethasone—atopic dermatitis	5.94e-05	0.00102	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Hydrocortisone—atopic dermatitis	5.93e-05	0.00102	CcSEcCtD
Dextropropoxyphene—Hypotension—Methylprednisolone—atopic dermatitis	5.92e-05	0.00102	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	5.82e-05	0.001	CcSEcCtD
Dextropropoxyphene—Vision blurred—Prednisone—atopic dermatitis	5.79e-05	0.000999	CcSEcCtD
Dextropropoxyphene—Insomnia—Triamcinolone—atopic dermatitis	5.74e-05	0.00099	CcSEcCtD
Dextropropoxyphene—Insomnia—Methylprednisolone—atopic dermatitis	5.73e-05	0.000988	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Prednisolone—atopic dermatitis	5.69e-05	0.000981	CcSEcCtD
Dextropropoxyphene—Shock—Dexamethasone—atopic dermatitis	5.67e-05	0.000977	CcSEcCtD
Dextropropoxyphene—Shock—Betamethasone—atopic dermatitis	5.67e-05	0.000977	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Triamcinolone—atopic dermatitis	5.66e-05	0.000976	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Betamethasone—atopic dermatitis	5.65e-05	0.000974	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Dexamethasone—atopic dermatitis	5.65e-05	0.000974	CcSEcCtD
Dextropropoxyphene—Agitation—Prednisone—atopic dermatitis	5.65e-05	0.000974	CcSEcCtD
Dextropropoxyphene—Tachycardia—Dexamethasone—atopic dermatitis	5.62e-05	0.00097	CcSEcCtD
Dextropropoxyphene—Tachycardia—Betamethasone—atopic dermatitis	5.62e-05	0.00097	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Triamcinolone—atopic dermatitis	5.59e-05	0.000964	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Methylprednisolone—atopic dermatitis	5.57e-05	0.000962	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Hydrocortisone—atopic dermatitis	5.55e-05	0.000958	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	5.51e-05	0.000951	CcSEcCtD
Dextropropoxyphene—Syncope—Prednisone—atopic dermatitis	5.51e-05	0.000951	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Prednisone—atopic dermatitis	5.4e-05	0.000932	CcSEcCtD
Dextropropoxyphene—Hypotension—Dexamethasone—atopic dermatitis	5.38e-05	0.000928	CcSEcCtD
Dextropropoxyphene—Hypotension—Betamethasone—atopic dermatitis	5.38e-05	0.000928	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Hydrocortisone—atopic dermatitis	5.33e-05	0.000919	CcSEcCtD
Dextropropoxyphene—Convulsion—Prednisone—atopic dermatitis	5.32e-05	0.000918	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Triamcinolone—atopic dermatitis	5.23e-05	0.000902	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Methylprednisolone—atopic dermatitis	5.22e-05	0.0009	CcSEcCtD
Dextropropoxyphene—Insomnia—Dexamethasone—atopic dermatitis	5.21e-05	0.000898	CcSEcCtD
Dextropropoxyphene—Insomnia—Betamethasone—atopic dermatitis	5.21e-05	0.000898	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	5.18e-05	0.000893	CcSEcCtD
Dextropropoxyphene—Discomfort—Prednisone—atopic dermatitis	5.17e-05	0.000892	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Prednisolone—atopic dermatitis	5.08e-05	0.000877	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Betamethasone—atopic dermatitis	5.07e-05	0.000874	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Dexamethasone—atopic dermatitis	5.07e-05	0.000874	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Methylprednisolone—atopic dermatitis	5.01e-05	0.000864	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	4.97e-05	0.000858	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Betamethasone—atopic dermatitis	4.97e-05	0.000858	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Hydrocortisone—atopic dermatitis	4.97e-05	0.000857	CcSEcCtD
Dextropropoxyphene—Shock—Prednisone—atopic dermatitis	4.93e-05	0.000851	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Prednisone—atopic dermatitis	4.92e-05	0.000848	CcSEcCtD
Dextropropoxyphene—Tachycardia—Prednisone—atopic dermatitis	4.89e-05	0.000844	CcSEcCtD
Dextropropoxyphene—Asthenia—Hydrocortisone—atopic dermatitis	4.84e-05	0.000834	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Dexamethasone—atopic dermatitis	4.75e-05	0.000819	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Betamethasone—atopic dermatitis	4.75e-05	0.000819	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Betamethasone—atopic dermatitis	4.71e-05	0.000812	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Dexamethasone—atopic dermatitis	4.71e-05	0.000812	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Triamcinolone—atopic dermatitis	4.68e-05	0.000807	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Methylprednisolone—atopic dermatitis	4.67e-05	0.000805	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Hydrocortisone—atopic dermatitis	4.61e-05	0.000796	CcSEcCtD
Dextropropoxyphene—Dizziness—Prednisolone—atopic dermatitis	4.56e-05	0.000787	CcSEcCtD
Dextropropoxyphene—Asthenia—Triamcinolone—atopic dermatitis	4.55e-05	0.000786	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Betamethasone—atopic dermatitis	4.55e-05	0.000785	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Dexamethasone—atopic dermatitis	4.55e-05	0.000785	CcSEcCtD
Dextropropoxyphene—Asthenia—Methylprednisolone—atopic dermatitis	4.54e-05	0.000784	CcSEcCtD
Dextropropoxyphene—Insomnia—Prednisone—atopic dermatitis	4.54e-05	0.000782	CcSEcCtD
Dextropropoxyphene—Dizziness—Hydrocortisone—atopic dermatitis	4.46e-05	0.000769	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Prednisone—atopic dermatitis	4.41e-05	0.000762	CcSEcCtD
Dextropropoxyphene—Rash—Prednisolone—atopic dermatitis	4.35e-05	0.000751	CcSEcCtD
Dextropropoxyphene—Dermatitis—Prednisolone—atopic dermatitis	4.35e-05	0.00075	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Methylprednisolone—atopic dermatitis	4.33e-05	0.000747	CcSEcCtD
Dextropropoxyphene—Headache—Prednisolone—atopic dermatitis	4.32e-05	0.000746	CcSEcCtD
Dextropropoxyphene—Constipation—Prednisone—atopic dermatitis	4.29e-05	0.00074	CcSEcCtD
Dextropropoxyphene—Vomiting—Hydrocortisone—atopic dermatitis	4.29e-05	0.000739	CcSEcCtD
Dextropropoxyphene—Rash—Hydrocortisone—atopic dermatitis	4.25e-05	0.000733	CcSEcCtD
Dextropropoxyphene—Dermatitis—Hydrocortisone—atopic dermatitis	4.25e-05	0.000732	CcSEcCtD
Dextropropoxyphene—Headache—Hydrocortisone—atopic dermatitis	4.22e-05	0.000728	CcSEcCtD
Dextropropoxyphene—Dizziness—Triamcinolone—atopic dermatitis	4.2e-05	0.000724	CcSEcCtD
Dextropropoxyphene—Dizziness—Methylprednisolone—atopic dermatitis	4.19e-05	0.000722	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Prednisone—atopic dermatitis	4.13e-05	0.000713	CcSEcCtD
Dextropropoxyphene—Asthenia—Betamethasone—atopic dermatitis	4.13e-05	0.000713	CcSEcCtD
Dextropropoxyphene—Asthenia—Dexamethasone—atopic dermatitis	4.13e-05	0.000713	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Prednisone—atopic dermatitis	4.1e-05	0.000707	CcSEcCtD
Dextropropoxyphene—Nausea—Prednisolone—atopic dermatitis	4.1e-05	0.000707	CcSEcCtD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—CCR3—atopic dermatitis	4.07e-05	0.00415	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	4.04e-05	0.00411	CbGpPWpGaD
Dextropropoxyphene—Vomiting—Triamcinolone—atopic dermatitis	4.04e-05	0.000696	CcSEcCtD
Dextropropoxyphene—Vomiting—Methylprednisolone—atopic dermatitis	4.03e-05	0.000695	CcSEcCtD
Dextropropoxyphene—Nausea—Hydrocortisone—atopic dermatitis	4e-05	0.000691	CcSEcCtD
Dextropropoxyphene—Rash—Triamcinolone—atopic dermatitis	4e-05	0.00069	CcSEcCtD
Dextropropoxyphene—Dermatitis—Triamcinolone—atopic dermatitis	4e-05	0.00069	CcSEcCtD
Dextropropoxyphene—Rash—Methylprednisolone—atopic dermatitis	3.99e-05	0.000689	CcSEcCtD
Dextropropoxyphene—Dermatitis—Methylprednisolone—atopic dermatitis	3.99e-05	0.000688	CcSEcCtD
Dextropropoxyphene—Headache—Triamcinolone—atopic dermatitis	3.98e-05	0.000686	CcSEcCtD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	3.97e-05	0.00405	CbGpPWpGaD
Dextropropoxyphene—Headache—Methylprednisolone—atopic dermatitis	3.97e-05	0.000684	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Prednisone—atopic dermatitis	3.96e-05	0.000684	CcSEcCtD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	3.96e-05	0.00404	CbGpPWpGaD
Dextropropoxyphene—Diarrhoea—Betamethasone—atopic dermatitis	3.94e-05	0.00068	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Dexamethasone—atopic dermatitis	3.94e-05	0.00068	CcSEcCtD
Dextropropoxyphene—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	3.91e-05	0.00398	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	3.9e-05	0.00397	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	3.9e-05	0.00397	CbGpPWpGaD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—CXCL10—atopic dermatitis	3.88e-05	0.00395	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	3.83e-05	0.0039	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	3.82e-05	0.00389	CbGpPWpGaD
Dextropropoxyphene—Dizziness—Dexamethasone—atopic dermatitis	3.81e-05	0.000657	CcSEcCtD
Dextropropoxyphene—Dizziness—Betamethasone—atopic dermatitis	3.81e-05	0.000657	CcSEcCtD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	3.78e-05	0.00385	CbGpPWpGaD
Dextropropoxyphene—Nausea—Triamcinolone—atopic dermatitis	3.77e-05	0.00065	CcSEcCtD
Dextropropoxyphene—Nausea—Methylprednisolone—atopic dermatitis	3.76e-05	0.000649	CcSEcCtD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CCL17—atopic dermatitis	3.75e-05	0.00382	CbGpPWpGaD
Dextropropoxyphene—Hypersensitivity—Prednisone—atopic dermatitis	3.69e-05	0.000637	CcSEcCtD
Dextropropoxyphene—Vomiting—Betamethasone—atopic dermatitis	3.66e-05	0.000632	CcSEcCtD
Dextropropoxyphene—Vomiting—Dexamethasone—atopic dermatitis	3.66e-05	0.000632	CcSEcCtD
Dextropropoxyphene—Rash—Betamethasone—atopic dermatitis	3.63e-05	0.000626	CcSEcCtD
Dextropropoxyphene—Rash—Dexamethasone—atopic dermatitis	3.63e-05	0.000626	CcSEcCtD
Dextropropoxyphene—Dermatitis—Betamethasone—atopic dermatitis	3.63e-05	0.000626	CcSEcCtD
Dextropropoxyphene—Dermatitis—Dexamethasone—atopic dermatitis	3.63e-05	0.000626	CcSEcCtD
Dextropropoxyphene—Headache—Betamethasone—atopic dermatitis	3.61e-05	0.000622	CcSEcCtD
Dextropropoxyphene—Headache—Dexamethasone—atopic dermatitis	3.61e-05	0.000622	CcSEcCtD
Dextropropoxyphene—Asthenia—Prednisone—atopic dermatitis	3.6e-05	0.000621	CcSEcCtD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CCL11—atopic dermatitis	3.58e-05	0.00365	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	3.57e-05	0.00364	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—CXCR3—atopic dermatitis	3.56e-05	0.00363	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	3.48e-05	0.00354	CbGpPWpGaD
Dextropropoxyphene—Diarrhoea—Prednisone—atopic dermatitis	3.43e-05	0.000592	CcSEcCtD
Dextropropoxyphene—Nausea—Dexamethasone—atopic dermatitis	3.42e-05	0.00059	CcSEcCtD
Dextropropoxyphene—Nausea—Betamethasone—atopic dermatitis	3.42e-05	0.00059	CcSEcCtD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	3.42e-05	0.00348	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	3.42e-05	0.00348	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	3.41e-05	0.00347	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—CXCL10—atopic dermatitis	3.41e-05	0.00347	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	3.35e-05	0.00341	CbGpPWpGaD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—CCL5—atopic dermatitis	3.34e-05	0.0034	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CCR3—atopic dermatitis	3.33e-05	0.00339	CbGpPWpGaD
Dextropropoxyphene—Dizziness—Prednisone—atopic dermatitis	3.32e-05	0.000572	CcSEcCtD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	3.3e-05	0.00336	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCL22—atopic dermatitis	3.25e-05	0.00331	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	3.24e-05	0.0033	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CCL27—atopic dermatitis	3.19e-05	0.00325	CbGpPWpGaD
Dextropropoxyphene—Vomiting—Prednisone—atopic dermatitis	3.19e-05	0.00055	CcSEcCtD
Dextropropoxyphene—Rash—Prednisone—atopic dermatitis	3.16e-05	0.000545	CcSEcCtD
Dextropropoxyphene—Dermatitis—Prednisone—atopic dermatitis	3.16e-05	0.000545	CcSEcCtD
Dextropropoxyphene—Headache—Prednisone—atopic dermatitis	3.14e-05	0.000542	CcSEcCtD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	3.13e-05	0.00319	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	3.09e-05	0.00314	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	3.03e-05	0.00308	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	3.02e-05	0.00308	CbGpPWpGaD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—CCR5—atopic dermatitis	3.01e-05	0.00307	CbGpPWpGaD
Dextropropoxyphene—Nausea—Prednisone—atopic dermatitis	2.98e-05	0.000514	CcSEcCtD
Dextropropoxyphene—OPRD1—GPCR ligand binding—TAC1—atopic dermatitis	2.97e-05	0.00302	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—NPS—atopic dermatitis	2.97e-05	0.00302	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	2.94e-05	0.00299	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—CCL5—atopic dermatitis	2.93e-05	0.00299	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CCR3—atopic dermatitis	2.92e-05	0.00297	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CXCR3—atopic dermatitis	2.91e-05	0.00296	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.9e-05	0.00296	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCL27—atopic dermatitis	2.9e-05	0.00295	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	2.89e-05	0.00294	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	2.89e-05	0.00294	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	2.88e-05	0.00293	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCL22—atopic dermatitis	2.85e-05	0.0029	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	2.83e-05	0.00288	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CCL27—atopic dermatitis	2.8e-05	0.00285	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.8e-05	0.00285	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	2.79e-05	0.00284	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	2.71e-05	0.00276	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.66e-05	0.00271	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	2.65e-05	0.00269	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	2.64e-05	0.00269	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	2.6e-05	0.00265	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	2.6e-05	0.00265	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	2.6e-05	0.00265	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	2.56e-05	0.00261	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	2.55e-05	0.0026	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	2.54e-05	0.00259	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	2.48e-05	0.00252	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	2.47e-05	0.00251	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.45e-05	0.0025	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	2.41e-05	0.00245	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.39e-05	0.00244	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	2.37e-05	0.00241	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	2.35e-05	0.00239	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.33e-05	0.00237	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	2.29e-05	0.00233	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	2.28e-05	0.00232	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	2.23e-05	0.00227	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	2.2e-05	0.00224	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	2.2e-05	0.00224	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	2.16e-05	0.0022	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	2.16e-05	0.0022	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	2.15e-05	0.00219	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.1e-05	0.00214	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	2.1e-05	0.00213	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.07e-05	0.00211	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	2.07e-05	0.0021	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	2.06e-05	0.0021	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	2.02e-05	0.00206	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.97e-05	0.00201	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	1.93e-05	0.00196	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	1.92e-05	0.00196	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	1.89e-05	0.00193	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	1.88e-05	0.00192	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	1.84e-05	0.00187	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	1.82e-05	0.00186	CbGpPWpGaD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.82e-05	0.00185	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	1.81e-05	0.00184	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	1.78e-05	0.00181	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.77e-05	0.00181	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.75e-05	0.00178	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	1.74e-05	0.00177	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	1.71e-05	0.00174	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	1.71e-05	0.00174	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	1.68e-05	0.00172	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	1.68e-05	0.00171	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	1.68e-05	0.00171	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	1.65e-05	0.00168	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	1.64e-05	0.00167	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	1.63e-05	0.00166	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	1.6e-05	0.00163	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	1.6e-05	0.00163	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.6e-05	0.00163	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	1.56e-05	0.00159	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	1.55e-05	0.00158	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	1.54e-05	0.00156	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	1.53e-05	0.00156	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	1.52e-05	0.00155	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	1.52e-05	0.00155	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	1.5e-05	0.00153	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	1.5e-05	0.00153	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	1.5e-05	0.00153	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	1.49e-05	0.00152	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	1.47e-05	0.0015	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	1.47e-05	0.0015	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.45e-05	0.00147	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	1.44e-05	0.00147	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.42e-05	0.00145	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	1.42e-05	0.00145	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	1.42e-05	0.00144	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	1.39e-05	0.00142	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	1.37e-05	0.00139	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	1.37e-05	0.00139	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	1.35e-05	0.00138	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.35e-05	0.00137	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	1.35e-05	0.00137	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	1.33e-05	0.00136	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	1.33e-05	0.00136	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	1.33e-05	0.00135	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	1.31e-05	0.00133	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.27e-05	0.00129	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	1.27e-05	0.00129	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	1.27e-05	0.00129	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GLB1—atopic dermatitis	1.24e-05	0.00127	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	1.24e-05	0.00127	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	1.24e-05	0.00127	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	1.24e-05	0.00126	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	1.24e-05	0.00126	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	1.24e-05	0.00126	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	1.22e-05	0.00124	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	1.21e-05	0.00123	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	1.2e-05	0.00122	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ADSL—atopic dermatitis	1.19e-05	0.00122	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	1.17e-05	0.00119	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	1.16e-05	0.00118	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	1.16e-05	0.00118	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	1.14e-05	0.00116	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	1.14e-05	0.00116	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	1.13e-05	0.00115	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	1.13e-05	0.00115	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	1.11e-05	0.00113	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	1.1e-05	0.00112	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	1.09e-05	0.00111	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	1.09e-05	0.00111	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.07e-05	0.00109	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	1.06e-05	0.00108	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	1.05e-05	0.00107	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	1.04e-05	0.00106	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	1.03e-05	0.00105	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	1.02e-05	0.00104	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	1.01e-05	0.00103	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	1.01e-05	0.00103	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	1e-05	0.00102	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	9.85e-06	0.001	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	9.67e-06	0.000984	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	9.36e-06	0.000953	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	9.17e-06	0.000934	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	9.17e-06	0.000934	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	9.11e-06	0.000928	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	9.04e-06	0.00092	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	8.99e-06	0.000916	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NPS—atopic dermatitis	8.99e-06	0.000916	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	8.94e-06	0.000911	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	8.85e-06	0.000901	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	8.82e-06	0.000898	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	8.62e-06	0.000878	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	8.48e-06	0.000863	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL5—atopic dermatitis	8.36e-06	0.000851	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	8.21e-06	0.000836	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	8.17e-06	0.000832	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	7.89e-06	0.000803	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NPS—atopic dermatitis	7.89e-06	0.000803	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GLB1—atopic dermatitis	7.79e-06	0.000794	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	7.73e-06	0.000787	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	7.7e-06	0.000784	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	7.64e-06	0.000778	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	7.48e-06	0.000761	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ADSL—atopic dermatitis	7.47e-06	0.000761	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL5—atopic dermatitis	7.33e-06	0.000747	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	7.13e-06	0.000726	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	6.94e-06	0.000706	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NPS—atopic dermatitis	6.66e-06	0.000679	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	6.66e-06	0.000679	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	6.54e-06	0.000666	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GLB1—atopic dermatitis	6.4e-06	0.000652	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GLB1—atopic dermatitis	6.34e-06	0.000646	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	6.25e-06	0.000637	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	6.23e-06	0.000634	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL5—atopic dermatitis	6.2e-06	0.000631	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	6.14e-06	0.000625	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ADSL—atopic dermatitis	6.14e-06	0.000625	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ADSL—atopic dermatitis	6.08e-06	0.000619	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	5.95e-06	0.000606	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NGF—atopic dermatitis	5.68e-06	0.000579	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.68e-06	0.000578	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	5.66e-06	0.000576	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	5.53e-06	0.000563	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.46e-06	0.000556	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	5.41e-06	0.000551	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	5.38e-06	0.000548	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	5.28e-06	0.000538	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	5.22e-06	0.000532	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NGF—atopic dermatitis	4.98e-06	0.000507	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	4.96e-06	0.000505	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	4.85e-06	0.000494	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	4.74e-06	0.000483	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	4.69e-06	0.000477	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.62e-06	0.000471	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.62e-06	0.00047	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	4.55e-06	0.000463	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	4.41e-06	0.000449	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NGF—atopic dermatitis	4.21e-06	0.000429	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	4.19e-06	0.000427	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GLB1—atopic dermatitis	4.18e-06	0.000426	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	4.11e-06	0.000418	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	4.1e-06	0.000417	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PPARA—atopic dermatitis	4.04e-06	0.000411	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ADSL—atopic dermatitis	4.01e-06	0.000408	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	4.01e-06	0.000408	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	3.47e-06	0.000354	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	3.34e-06	0.00034	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL2—atopic dermatitis	3.19e-06	0.000325	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	3.18e-06	0.000324	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	2.94e-06	0.000299	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	2.93e-06	0.000298	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL2—atopic dermatitis	2.8e-06	0.000285	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	2.79e-06	0.000284	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	2.58e-06	0.000263	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PPARA—atopic dermatitis	2.53e-06	0.000258	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	2.48e-06	0.000252	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL2—atopic dermatitis	2.37e-06	0.000241	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	2.36e-06	0.00024	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	2.18e-06	0.000222	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PPARA—atopic dermatitis	2.08e-06	0.000211	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PPARA—atopic dermatitis	2.06e-06	0.00021	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL6—atopic dermatitis	1.88e-06	0.000191	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL6—atopic dermatitis	1.65e-06	0.000168	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL6—atopic dermatitis	1.39e-06	0.000142	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.36e-06	0.000138	CbGpPWpGaD
